Globant SA

Globant S.A. was the largest single detractor from the WS Amati Global Innovation Fund during the second quarter of 2026. The fund, managed by AMAti Global Investors, stated that the US-listed IT services and digital engineering business suffered from excessive extrapolation by investors, and the firm has been gently adding to the position on weakness. Globant shares closed at $31.30 on July 24, 2026, with a market capitalization of $1.35 billion, and have lost 64.62% over the past 52 weeks. The fund outperformed the MSCI ACWI benchmark in the quarter, driven by diversified exposure beyond headline AI firms, though software and IT services faced skepticism.

Accenture shares fell 17% after the company narrowed its full-year revenue growth guidance to 3-4% from a prior range of 3-5%, despite reporting fiscal third-quarter results that were largely in line with estimates. Revenue rose 6% year over year and earnings increased 9%, slightly beating expectations, but the lowered outlook weighed heavily on the stock. The IT consulting industry has been under significant pressure, with Accenture's shares up only 32% over the past decade and down roughly 50% from their high, while peers like Globant and EXL Services have fared even worse. Analysts note that while current financials remain stable, the growing adoption of AI threatens to disrupt traditional consulting models, as businesses increasingly turn to AI for personalized advice rather than human consultants. Accenture also announced over $4 billion in cybersecurity acquisitions, which are not yet profitable and could temporarily depress future earnings.

Pomerantz LLP has filed a class action lawsuit against Globant SA, alleging securities fraud or other unlawful business practices. Investors who purchased or acquired Globant securities during the Class Period have until June 23, 2026, to seek appointment as Lead Plaintiff. The complaint follows a series of stock declines after Globant disclosed weakening Latin American revenue and a challenging macroeconomic environment, including a 27.81% drop on February 21, 2025, a 23.61% drop on May 16, 2025, and a 14.93% drop on August 15, 2025. The firm, founded by the late Abraham L. Pomerantz, is recognized for its work in corporate, securities, and antitrust class litigation.

The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of LKQ Corporation, Regencell Bioscience Holdings Limited, and Globant S.A. The lead plaintiff deadline for LKQ is June 22, 2026, for a class period spanning February 27, 2023 to July 23, 2025, with allegations that FinishMaster was losing major customers and that risks from the Uni-Select acquisition had already materialized. Regencell investors have until June 23, 2026, for claims covering October 28, 2024 to October 31, 2025, alleging the company was vulnerable to market manipulation and exposed investors to significant financial risk. Globant's deadline is also June 23, 2026, for a class period from February 15, 2024 to August 14, 2025, with allegations of decreasing demand across Latin America and project cancellations by Latin American clients.

The Schall Law Firm reminds investors of a class action lawsuit against Globant S.A. for alleged securities fraud. Investors who purchased Globant securities between February 15, 2024 and August 14, 2025, inclusive, are encouraged to contact the firm before the June 23, 2026 deadline. The complaint alleges Globant made false and misleading statements about its Latin American pivot, which suffered from declined demand and project cancellations, while the company froze wages in certain countries, hurting morale and client service. The Schall Law Firm specializes in shareholder rights litigation and represents investors worldwide.

Rosen Law Firm reminds purchasers of Globant S.A. common stock during the class period from February 15, 2024 to August 14, 2025 of the June 23, 2026 lead plaintiff deadline in a securities class action. If you purchased Globant common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The lawsuit alleges that Globant misled investors about the success of its $1 billion strategic pivot to increase Latin American business, concealing declining demand, client defections, project cancellations, and employee turmoil from wage freezes in Mexico and Argentina. Investors with losses exceeding $100,000 are encouraged to secure counsel before the deadline.

Faruqi & Faruqi, LLP reminds investors in Globant S.A. of the June 23, 2026 deadline to seek lead plaintiff appointment in a securities class action lawsuit. The lawsuit alleges that Globant and its executives made false and misleading statements about the company's Latin American operations, concealing the true state of the business. On August 14, 2025, Globant disclosed mixed second-quarter results, a 2% headcount reduction of approximately 1,000 employees, and a $47.6 million restructuring charge, causing its stock price to drop from $78.12 to $66.46 per share in one day. Investors who purchased or acquired Globant securities between February 15, 2024 and August 14, 2025 may be eligible to participate.

Bronstein, Gewirtz & Grossman LLC has filed a class action lawsuit against Globant S.A. and certain officers, alleging violations of federal securities laws. The suit covers investors who purchased or acquired Globant securities between February 15, 2024 and August 14, 2025. The complaint claims that Globant made false and misleading statements about its Latin American operations, which were actually experiencing declining demand, client defections, and project cancellations, while the company froze employee wages in Mexico and Argentina, causing turmoil and degraded client services. Investors have until June 23, 2026 to seek lead plaintiff appointment. The law firm is handling the case on a contingency fee basis.